文献速递慢性肾脏病肾小球疾病遗传性与小管间质肾病

ALG9突变携带者发生肾囊肿和肝囊肿

ALG9 Mutation Carriers Develop Kidney and Liver Cysts.
PubMed 文献 · J Am Soc Nephrol · 2019-08-08

研究通过全外显子测序在122例未明确基因诊断的ADPKD或多囊肝患者中发现ALG9为候选基因,体外实验证实Alg9失活导致PC1成熟和糖基化缺陷。在人群外显子测序队列中,8例ALG9功能缺失突变携带者中7例(88%)在50岁后影像检查发现至少4个肾囊肿,而匹配对照均无肾囊肿。结论认为ALG9是ADPKD谱系的新致病基因。

要点

  • ALG9功能缺失突变可导致类似ADPKD的多囊肾和多囊肝表型。
  • Alg9失活引起多囊蛋白-1(PC1)成熟和糖基化缺陷。
  • 50岁以上ALG9突变携带者中88%有至少4个肾囊肿,对照无。

核心结论

  • ALG9是遗传异质性ADPKD谱系中的新致病基因。
  • 在基因定义队列中进行表型特征分析有助于验证新致病基因并提供基因型-表型关联。

研究设计与样本

  • 研究对122例临床诊断为ADPKD或多囊肝但基因未明的患者进行全外显子测序以识别候选基因ALG9。
  • 采用体外细胞实验检测PC1蛋白成熟以功能验证ALG9突变。
  • 在大型人群外显子测序队列中识别ALG9功能缺失突变携带者及匹配的非携带对照,评估多囊表型。

主要发现

  • 临床队列中2例患者携带罕见的ALG9功能缺失变异。
  • 体外实验显示Alg9失活导致PC1成熟受损和糖基化缺陷。
  • 人群队列中8例ALG9突变携带者50岁后接受腹部影像检查,7例(88%)有至少4个肾囊肿,而匹配对照均无。

关键数值与推荐

  • ALG9功能缺失突变携带者中,50岁后影像检查发现至少4个肾囊肿的比例为88%(7/8)。
  • 匹配的非携带对照中无人出现至少4个肾囊肿。

临床怎么用

  • 对临床诊断ADPKD或多囊肝但常见基因突变阴性的患者,可考虑ALG9基因检测。
  • ALG9突变携带者应进行肾脏和肝脏影像学监测。

局限性

  • 研究未报告ALG9突变携带者与对照的具体样本量、P值或置信区间。
  • 研究未提供ALG9相关多囊肾病的长期预后或治疗数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mutations in PKD1 or PKD2 cause typical autosomal dominant polycystic kidney disease (ADPKD), the most common monogenic kidney disease. Dominantly inherited polycystic kidney and liver diseases on the ADPKD spectrum are also caused by mutations in at least six other genes required for protein biogenesis in the endoplasmic reticulum, the loss of which results in defective production of the PKD1 gene product, the membrane protein polycystin-1 (PC1). METHODS: We used whole-exome sequencing in a cohort of 122 patients with genetically unresolved clinical diagnosis of ADPKD or polycystic liver disease to identify a candidate gene, ALG9, and in vitro cell-based assays of PC1 protein maturation to functionally validate it. For further validation, we identified carriers of ALG9 loss-of-function mutations and noncarrier matched controls in a large exome-sequenced population-based cohort and evaluated the occurrence of polycystic phenotypes in both groups. RESULTS: Two patients in the clinically defined cohort had rare loss-of-function variants in ALG9, which encodes a protein required for addition of specific mannose molecules to the assembling N-glycan precursors in the endoplasmic reticulum lumen. In vitro assays showed that inactivation of Alg9 results in impaired maturation and defective glycosylation of PC1. Seven of the eight (88%) cases selected from the population-based cohort based on ALG9 mutation carrier state who had abdominal imaging after age 50; seven (88%) had at least four kidney cysts, compared with none in matched controls without ALG9 mutations. CONCLUSIONS: ALG9 is a novel disease gene in the genetically heterogeneous ADPKD spectrum. This study supports the utility of phenotype characterization in genetically-defined cohorts to validate novel disease genes, and provide much-needed genotype-phenotype correlations.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Besse W, Chang AR, Luo JZ, et al. ALG9 Mutation Carriers Develop Kidney and Liver Cysts. J Am Soc Nephrol. 2019. PMID: 31395617. doi:10.1681/ASN.2019030298

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。